Tuna and Algae Omega-3 Ingredients Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The Tuna And Algae Omega-3 Ingredients Market attained a value of USD 4.19 Billion in 2025 and is projected to expand at a CAGR of around 4.8% through 2035. With increasing consumer awareness of the cardiovascular, cognitive, and anti-inflammatory health benefits of EPA and DHA omega-3 fatty acids driving dietary supplement and functional food demand, rising preference for sustainable and plant-based algae-derived omega-3 alternatives to fish oil among vegan and environmentally conscious consumers, growing adoption in infant formula, clinical nutrition, and pharmaceutical applications requiring high-purity DHA and EPA ingredients, and technological advances in microencapsulation and bioavailability enhancement expanding application scope across food and beverage categories, the market is set to achieve USD 6.21 Billion by 2035.

Key Market Trends and Insights

• North America dominated the Tuna And Algae Omega-3 Ingredients Market in 2025, accounting for approximately 35% of global revenue, and is projected to maintain its leading position over the forecast period driven by high consumer supplement adoption rates - with approximately 25% of American adults using omega-3 supplements according to the National Institutes of Health - and the strong regulatory acceptance and clinical evidence base for DHA and EPA health claims.
• By Type, the Tuna Omega-3 Ingredient segment held the largest revenue share in 2025 at approximately 60%, driven by its established use in dietary supplements, functional foods, and pet food, and the high EPA and DHA concentration achievable through refined tuna oil processing. However, the Algae Omega-3 Ingredient segment is growing at a significantly faster CAGR of approximately 13.36%, driven by plant-based diet trends and sustainability imperatives.
• By Application, the Dietary Supplements segment is expected to register the largest CAGR over the forecast period, driven by global health consciousness trends, aging population dietary supplementation demand, and the growing body of clinical evidence supporting omega-3 supplementation in cardiovascular disease prevention, cognitive health maintenance, and maternal and infant health.

Market Size and Forecast

• Market Size in 2025: USD 4.19 Billion
• Projected Market Size in 2035: USD 6.21 Billion
• CAGR from 2026-2035: 4.8%
• Fastest-Growing Sub-Segment: Algae Omega-3 Ingredients (~13% CAGR)

The Tuna And Algae Omega-3 Ingredients Market was valued at USD 4.19 Billion in 2025, representing a mature but rapidly evolving ingredient category at the intersection of nutraceuticals, sustainable food production, and precision nutrition science. The market encompasses tuna oil-derived omega-3 concentrates (primarily EPA and DHA) and microalgae-derived DHA and EPA ingredients, serving dietary supplement manufacturers, infant formula producers, functional food and beverage companies, pharmaceutical producers, and animal nutrition formulators. North America leads with approximately 35% of global market revenue, followed by Europe at approximately 30%, reflecting high consumer awareness of omega-3 health benefits and well-established supplement purchasing behavior in these markets. Tuna-derived omega-3 ingredients - which typically contain EPA and DHA concentrations of 10-20% in crude form and up to 80%+ in concentrated refined form - constitute the largest product category by revenue, supported by decades of regulatory approvals and extensive clinical evidence.

The tuna and algae omega-3 ingredients market growth is being fundamentally reshaped by the global plant-based nutrition movement and sustainability concerns about marine resource depletion. Algae-derived omega-3 ingredients offer a compelling value proposition: they provide DHA and EPA at concentrations exceeding 40-50% (compared to typical tuna oil's 10-20%), are sourced from controlled fermentation environments without marine ecosystem disruption, produce no risk of heavy metal contamination, and meet the ethical and dietary requirements of vegan and vegetarian consumers. The algae-based sub-segment was valued at USD 1.26 Billion in 2025 and is growing at 13.36% CAGR - a rate that significantly outpaces the broader market - as major ingredient companies including DSM-Firmenich (life's DHA), Corbion, and ADM expand production capacity for algal oil at commercial scale.

Key Takeaways

• Key Takeaway 1: North America commands approximately 35% of global market revenue in 2025, supported by high omega-3 supplement consumption rates and strong regulatory health claim recognition for DHA and EPA.
• Key Takeaway 2: Tuna Omega-3 Ingredients lead by type in 2025 with approximately 60% share, while Algae Omega-3 Ingredients are growing at ~13.36% CAGR - reflecting the accelerating sustainability-driven shift toward plant-based omega-3 sources.
• Key Takeaway 3: The market is projected to grow at a CAGR of 4.8% during 2026-2035, sustained by dietary supplement demand growth, infant nutrition DHA requirements, and the accelerating commercial scale-up of algae-based omega-3 production.